Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Landfar Bio-medicine Co's Operating Margin % or its related term are showing as below:
SZSE:000504'
s Operating Margin % Range Over the Past 10 Years
Min: -39.9 Med: -2.67 Max: 13.92
Current: 10.1
SZSE:000504's Operating Margin % is ranked better than 81.26% of 939
companies
in the Biotechnology industry
Industry Median: -86.77
vs SZSE:000504: 10.10
Landfar Bio-medicine Co (SZSE:000504) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Landfar Bio-medicine Co Operating Margin % Related Terms
Landfar Bio-medicine Co Operating Margin % Historical Data
* Premium members only.
The historical data trend for Landfar Bio-medicine Co's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SZSE:000504 vs VRTX, REGN, ALNY: Operating Margin % Comparison
For the Biotechnology subindustry, Landfar Bio-medicine Co's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Landfar Bio-medicine Co Operating Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Landfar Bio-medicine Co's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Landfar Bio-medicine Co's Operating Margin % falls into.
Landfar Bio-medicine Co Operating Margin % Calculation
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Landfar Bio-medicine Co's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Landfar Bio-medicine Co (SZSE:000504) has a Operating Margin % of 11.26% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Landfar Bio-medicine Co and its competitors. According to the industry distribution chart, Landfar Bio-medicine Co ranks #176 out of 939 companies in the Biotechnology industry, placing it in the top 18.7%.
Is Landfar Bio-medicine Co's Operating Margin % too high?
Landfar Bio-medicine Co's current Operating Margin % is 11.26%. Based on the distribution chart, Landfar Bio-medicine Co ranks #176 out of 939 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Landfar Bio-medicine Co has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Landfar Bio-medicine Co's Operating Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Landfar Bio-medicine Co ranks #176 out of 939 companies for Operating Margin %. This places Landfar Bio-medicine Co in the top 19% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Biotechnology company?
A good Operating Margin % depends on the Biotechnology industry context. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Landfar Bio-medicine Co and its competitors. Landfar Bio-medicine Co's current Operating Margin % is 11.26%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Landfar Bio-medicine Co stock overvalued right now?
Based on GuruFocus' analysis, Landfar Bio-medicine Co (SZSE:000504) is currently considered Possible Value Trap. The stock's GF Value™ is ¥38.06, compared to a current price of ¥7.74 — trading 79.7% below its estimated fair value. The current Operating Margin % is 11.26%. Landfar Bio-medicine Co's overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Landfar Bio-medicine Co (SZSE:000504), the current Operating Margin % is 11.26% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Landfar Bio-medicine Co (SZSE:000504) Overvalued in 2026?
Based on GuruFocus' analysis, Landfar Bio-medicine Co stock appears to be undervalued.
The current stock price of ¥7.74 is trading 79.7% below its estimated GF Value™ of ¥38.06.
GuruFocus considers Landfar Bio-medicine Co to be Possible Value Trap.
Key valuation signals for SZSE:000504:
Operating Margin %: 11.26%
GF Value™: ¥38.06 vs. price of ¥7.74 (79.7% below fair value)
No single metric tells the full story. See the SZSE:000504 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Address3rd Floor, Building B1, Lugu Technology Innovation and Entrepreneurship Park, No. 1698, Yuelu West Avenue, High-tech Zone, Hunan Province, Changsha, CHN, 410015
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:000504 has been successfully added to your 
